Moonlake Immunotherapeutics Stock Price on February 26, 2024
| MLTX Stock | USD 53.54 0.31 0.58% |
Below is the normalized historical share price chart for MoonLake Immunotherapeutics extending back to October 20, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of MoonLake Immunotherapeuti stands at 53.54, as last reported on the 12th of December 2024, with the highest price reaching 54.50 and the lowest price hitting 53.00 during the day.
If you're considering investing in MoonLake Stock, it is important to understand the factors that can impact its price. At this stage we consider MoonLake Stock to be very steady. MoonLake Immunotherapeuti has Sharpe Ratio of 0.0388, which conveys that the firm had a 0.0388% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for MoonLake Immunotherapeuti, which you can use to evaluate the volatility of the firm. Please verify MoonLake Immunotherapeuti's Risk Adjusted Performance of 0.0659, downside deviation of 3.38, and Mean Deviation of 2.46 to check out if the risk estimate we provide is consistent with the expected return of 0.12%.
At this time, MoonLake Immunotherapeuti's Total Stockholder Equity is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to rise to about 552.9 M in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 27.8 M in 2024. . At this time, MoonLake Immunotherapeuti's Price Book Value Ratio is fairly stable compared to the past year. Price Earnings To Growth Ratio is likely to rise to 1.29 in 2024, whereas Price Earnings Ratio is likely to drop (86.51) in 2024. MoonLake Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 20th of October 2020 | 200 Day MA 46.5806 | 50 Day MA 50.37 | Beta 1.278 |
MoonLake |
Sharpe Ratio = 0.0388
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | MLTX | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.11 actual daily | 27 73% of assets are more volatile |
Expected Return
| 0.12 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.04 actual daily | 3 97% of assets perform better |
Based on monthly moving average MoonLake Immunotherapeuti is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of MoonLake Immunotherapeuti by adding it to a well-diversified portfolio.
Price Book 6.9562 | Book Value 7.743 | Enterprise Value 2.8 B | Enterprise Value Ebitda (41.53) | Shares Float 26 M |
Related Headline
Compass Therapeutics Headline on 26th of February 2024
Compass Therapeutics exotic insider transaction detected by Gordon Carl L
Filed transaction by Compass Therapeutics Inc director. Unconventional Insider trading
MoonLake Immunotherapeuti Valuation on February 26, 2024
It is possible to determine the worth of MoonLake Immunotherapeuti on a given historical date. On February 26, 2024 MoonLake was worth 52.05 at the beginning of the trading date compared to the closed value of 52.12. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of MoonLake Immunotherapeuti stock. Still, in general, we apply an absolute valuation method to find MoonLake Immunotherapeuti's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of MoonLake Immunotherapeuti where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against MoonLake Immunotherapeuti's related companies.
| Open | High | Low | Close | Volume | |
| 52.50 | 53.32 | 52.00 | 52.05 | 340,321 | |
02/26/2024 | 52.05 | 53.54 | 50.65 | 52.12 | 647,097 |
| 52.28 | 55.00 | 51.76 | 54.76 | 774,146 |
| Backtest MoonLake Immunotherapeuti | | | MoonLake Immunotherapeuti History | | | MoonLake Immunotherapeuti Valuation | Previous | Next |
MoonLake Immunotherapeuti Trading Date Momentum on February 26, 2024
| On February 27 2024 MoonLake Immunotherapeutics was traded for 54.76 at the closing time. The top price for the day was 55.00 and the lowest listed price was 51.76 . The trading volume for the day was 774.1 K. The trading history from February 27, 2024 was a factor to the next trading day price jump. The trading delta at closing time against the next closing price was 5.07% . The trading delta at closing time against the current closing price is 11.88% . |
MoonLake Immunotherapeuti Fundamentals Correlations and Trends
By evaluating MoonLake Immunotherapeuti's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among MoonLake Immunotherapeuti's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. MoonLake financial account trend analysis is a perfect complement when working with valuation or volatility modules.About MoonLake Immunotherapeuti Stock history
MoonLake Immunotherapeuti investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for MoonLake is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in MoonLake Immunotherapeuti will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing MoonLake Immunotherapeuti stock prices may prove useful in developing a viable investing in MoonLake Immunotherapeuti
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 49.1 M | 27.8 M | |
| Net Loss | -45 M | -42.7 M |
MoonLake Immunotherapeuti Stock Technical Analysis
MoonLake Immunotherapeuti technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
MoonLake Immunotherapeuti Period Price Range
Low | December 12, 2024
| High |
0.00 | 0.00 |
MoonLake Immunotherapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
MoonLake Immunotherapeuti December 12, 2024 Market Strength
Market strength indicators help investors to evaluate how MoonLake Immunotherapeuti stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading MoonLake Immunotherapeuti shares will generate the highest return on investment. By undertsting and applying MoonLake Immunotherapeuti stock market strength indicators, traders can identify MoonLake Immunotherapeutics entry and exit signals to maximize returns
MoonLake Immunotherapeuti Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for MoonLake Immunotherapeuti's price direction in advance. Along with the technical and fundamental analysis of MoonLake Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of MoonLake to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0659 | |||
| Jensen Alpha | (0.01) | |||
| Total Risk Alpha | (0.27) | |||
| Sortino Ratio | 0.041 | |||
| Treynor Ratio | 0.1112 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for MoonLake Stock Analysis
When running MoonLake Immunotherapeuti's price analysis, check to measure MoonLake Immunotherapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MoonLake Immunotherapeuti is operating at the current time. Most of MoonLake Immunotherapeuti's value examination focuses on studying past and present price action to predict the probability of MoonLake Immunotherapeuti's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MoonLake Immunotherapeuti's price. Additionally, you may evaluate how the addition of MoonLake Immunotherapeuti to your portfolios can decrease your overall portfolio volatility.